Skip to main navigation
  • Events
  • Contact
  • Home
  • About us
  • Products
  • Partnering
  • Investors
    • Stock Information
    • Events & Presentations
    • Financial Information
      • Annual Reports
      • Results Center
      • SEC Filings
      • Listing Prospectus
    • Financial Calendar
    • Shareholder Meeting
    • Analyst Coverage
    • Corporate Governance
      • Committee Composition
    • Contact us
  • News
  • Events
  • Contact
  • Home
  • About us
    • Overview
    • Strategy
    • Management team
    • Board of Directors
    • Careers
  • Products
    • Overview
    • Autoimmunity
      • ARGX-113
    • Oncology
      • ARGX-110
      • ARGX-111
      • ARGX-115
    • Discovery programs
    • Technology
  • Partnering
    • Opportunities
    • Partnerships
    • Innovative Access Program
  • Investors
    • Stock Information
    • Events & Presentations
    • Financial Information
      • Annual Reports
      • Results Center
      • SEC Filings
      • Listing Prospectus
    • Financial Calendar
    • Shareholder Meeting
    • Analyst Coverage
    • Corporate Governance
      • Committee Composition
    • Contact us
  • News
    • Press releases
    • Events & Presentations
    • Downloads
  • Home
  • Investors
  •  
  • S-8

SEC Filing Details

Document Details

Form
S-8
Filing Date
Dec 17, 2025
Document Date
Dec 17, 2025
Form Description
Securities offered to employees pursuant to employee benefit plans
Filing Group
Registration Statements
Company
argenx
Issuer
ARGENX SE

Filing Formats

View HTML
Download PDF
Download DOC
Download XLS

XBRL

XBRL Viewer
XML - XBRL INSTANCE DOCUMENT

Stock info

Read more 

FY 2018 Business Update & Financial Results

Replay webcast 

Innovative Access Program

Collaboration opportunities under our Innovative Access Program 
  • Print
  • RSS
  • Email Alerts
Contact

argenx SE
Breda, The Netherlands
T +31 763 030 488

info@argenx.com

 

argenx BVBA
Zwijnaarde, Belgium
T +32 9 310 34 00

Downloads
ARGX-113 poster MG Conference NY Annual report 2016 Corporate presentation
Follow us

2026 © argenx

| Disclaimer | Cookie policy | Sitemap
  • Home
  • About us
  • Products
  • Partnering
  • Investors
  • News
Created by Cantilis